Systems medicine advances in interstitial lung disease

Area of Science:

• Pulmonary Medicine
• Systems Biology
• Genomics

Background:

• Fibrotic lung diseases result from complex interactions between environmental factors, disrupted homeostasis, DNA repair, and immune responses.
• Interstitial lung diseases (ILDs) represent a diverse category of challenging fibrotic conditions.

Purpose of the Study:

• To review the advancements in systems medicine approaches applied to interstitial lung diseases (ILDs) over the last five years.
• To highlight the benefits of systems medicine in improving ILD diagnostics, understanding disease heterogeneity, and enabling personalized treatment strategies.

Main Methods:

• Holistic analysis integrating systems biology platforms with clinical data.
• Review of recent literature (past 5 years) on systems medicine applications in ILDs.

Main Results:

• Systems medicine offers significant advantages in diagnosing ILDs.
• Improved characterization of phenotypical variations within ILD patient populations.
• Enhanced patient stratification for predicting outcomes and tailoring therapies.

Conclusions:

• Systems medicine is revolutionizing the study and management of ILDs.
• This approach facilitates a deeper understanding of disease mechanisms and progression.
• Future applications promise more precise and effective personalized medicine for fibrotic lung diseases.